152 related articles for article (PubMed ID: 3500817)
1. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.
Fan JL; Himeno K; Tsuru S; Nomoto K
Clin Exp Immunol; 1987 Oct; 70(1):94-101. PubMed ID: 3500817
[TBL] [Abstract][Full Text] [Related]
2. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
Hagiwara E; Okubo T; Aoki I; Ohno S; Tsuji T; Ihata A; Ueda A; Shirai A; Okuda K; Miyazaki J; Ishigatsubo Y
Cytokine; 2000 Jul; 12(7):1035-41. PubMed ID: 10880249
[TBL] [Abstract][Full Text] [Related]
3. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
4. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis.
Shiraki M; Fujiwara M; Tomura S
Clin Exp Immunol; 1984 Feb; 55(2):333-9. PubMed ID: 6607792
[TBL] [Abstract][Full Text] [Related]
5. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
Merino R; Iwamoto M; Fossati L; Izui S
J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
[TBL] [Abstract][Full Text] [Related]
6. Treatment of autoimmune MRL/lpr mice with anti-B220 monoclonal antibody reduces the level of anti-DNA antibodies and lymphadenopathies.
Asensi V; Kimeno K; Kawamura I; Sakumoto M; Nomoto K
Immunology; 1989 Oct; 68(2):204-8. PubMed ID: 2478453
[TBL] [Abstract][Full Text] [Related]
7. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice.
Bloom DD; Davignon JL; Cohen PL; Eisenberg RA; Clarke SH
J Immunol; 1993 Feb; 150(4):1579-90. PubMed ID: 8432994
[TBL] [Abstract][Full Text] [Related]
8. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
[TBL] [Abstract][Full Text] [Related]
9. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
10. Signals required for activation and growth of autoimmune T lymphocytes.
Santoro TJ; Malek TR; Rosenberg YJ; Morse HC; Steinberg AD
J Mol Cell Immunol; 1984; 1(6):347-56. PubMed ID: 6086044
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin plus irradiation. Combined treatment of autoimmune MRL/l mice.
Fan JL; Himeno K; Hussain A; Nomoto K
Biotherapy; 1989; 1(2):97-102. PubMed ID: 2641464
[TBL] [Abstract][Full Text] [Related]
12. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
Kobayashi K; Hamano T; Kakishita E
Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
Liu CP; Tsai WJ; Shen CC; Lin YL; Liao JF; Chen CF; Kuo YC
Eur J Pharmacol; 2006 Feb; 531(1-3):270-9. PubMed ID: 16413531
[TBL] [Abstract][Full Text] [Related]
14. Injection of IL-12- and IL-18-encoding plasmids ameliorates the autoimmune pathology of MRL/Mp-Tnfrsf6lpr mice: synergistic effect on autoimmune symptoms.
Neumann D; Tschernig T; Popa D; Schmiedl A; Pérez de Lema G; Resch K; Martin MU
Int Immunol; 2006 Dec; 18(12):1779-87. PubMed ID: 17077176
[TBL] [Abstract][Full Text] [Related]
15. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
Treadwell EL; Cohen P; Williams D; O'Brien K; Volkman A; Eisenberg R
J Immunol; 1993 Jan; 150(2):695-9. PubMed ID: 8419494
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunological effects of cholera toxin on autoimmune MRL/lpr and BXSB mice.
Zhou NN; Nakai S; Oka M; Nagasawa H; Himeno K
Microbiol Immunol; 1992; 36(7):745-56. PubMed ID: 1406377
[TBL] [Abstract][Full Text] [Related]
17. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
[TBL] [Abstract][Full Text] [Related]
19. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
[TBL] [Abstract][Full Text] [Related]
20. Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
Rodgers KE
J Autoimmun; 1997 Aug; 10(4):367-73. PubMed ID: 9237800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
